Formulaciones opioides que disuaden de su uso recreativo: más preguntas que respuestas sobre su utilidad

• Autores: Borja Mugabure Bujedo
• Localización: Revista de la Sociedad Española del Dolor (SED), ISSN 1134-8046, ISSN-e 2254-6189, Vol. 27, Nº. 1 1, 2020, págs. 61-62
• Idioma: español
• DOI: 10.20986/resed.2018.3645/2017
• Títulos paralelos:
  • Opioid formulations that prevent the recreational use: more questions than answers about their utility
• Enlaces
  • Texto Completo Ejemplar
• Referencias bibliográficas
  • Jones, CM,Mack, KA,Paulozzi, LJ. (2013). Pharmaceutical overdose deaths, United States, 2010. JAMA. 309. 657
  • (2015). Center for Drug Evaluation and Research (CDER) FDA: Abuse deterrent opioids - evaluation and labeling guidance for industry. U.S....
  • Cicero, TJ,Ellis, MS. (2015). Abuse deterrent formulations and the prescription opioid epidemic in the United States: Lessons learned from...
  • Brown Jr, RE. (2017). Abuse-deterrent formulations of opioids: Many questions still to answer. J Opioid Manag. 13. 353
  • Setnik, B. (2017). Opioid overdose protection: an inevitable need to address an alarming epidemic. J Opioid Manag. 13. 363
  • Dart, RC,Iwanicki, JL,Dasgupta, N,Cicero, TJ,Schnoll, SH. (2017). Do abuse deterrent opioid formulations work. J Opioid Manag. 13. 365
  • Hale, ME,Moe, D,Bond, M,Gasior, M,Malamut, R. (2016). Abuse-deterrent formulations of prescription opioid analgesics in the management of...